INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $421,000 | -45.9% | 80,000 | -19.2% | 0.14% | -66.7% |
| Q4 2015 | $778,000 | -58.2% | 99,000 | -55.1% | 0.42% | -51.8% |
| Q3 2015 | $1,863,000 | -51.5% | 220,618 | -37.1% | 0.87% | -29.6% |
| Q2 2015 | $3,841,000 | -43.1% | 350,604 | -27.5% | 1.24% | -23.7% |
| Q1 2015 | $6,754,000 | -2.4% | 483,262 | +18.0% | 1.63% | -10.5% |
| Q4 2014 | $6,922,000 | +57.7% | 409,715 | +25.4% | 1.82% | +16.4% |
| Q3 2014 | $4,388,000 | +187.2% | 326,821 | +172.4% | 1.56% | -11.5% |
| Q2 2014 | $1,528,000 | +7.1% | 120,000 | 0.0% | 1.77% | +29.1% |
| Q1 2014 | $1,427,000 | – | 120,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
| BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
| Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
| Bleichroeder LP | 250,000 | $138,750 | 0.03% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
| Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
| Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
| Virtu Financial LLC | 66,537 | $37 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
| Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |